Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer 1.0 Credit / Breast Cancer, Endocrinology, Diabetes & Metabolism, Oncology, Patient Safety, ...

Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes. Interest in peptides is growing among both patients ...

Throughout October, key recognition dates highlight the profession’s diverse workforce, including National Student ...

Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.

A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit PrEP uptake. The faculty examine what sustains PrEP deserts and how to ...

At eligible safety-net organizations, the 340B Drug Pricing Program may also support access. However, discounted acquisition costs do not establish a patient’s final charge. Pharmacists should confirm ...

Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities. Melissa McGivney, PharmD, FAPhA, FCCP, ...

Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities. Community pharmacy’s business model is under ...

The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy. The FDA approved pritelivir (Hovilpri) oral tablets for the treatment of ...

The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance. A novel approach to tracking pneumococcal disease could be on the horizon, ...